SYMPATH Symposium on Targeting Synucleinopathies par Clémence Fouquet 12.01.2017 à 06h59
SYMPATH Symposium on Targeting Synucleinopathies
The SYMPATH Symposium on Targeting Synucleinopathies, which will be held in Vienna on March 28th, 2017, will bring together world-leading experts from Europe and the US to discuss recent progress in developing therapeutic vaccinations targeting Parkinson’s disease (PD) and Multiple System Atrophy (MSA). The agenda includes pathogenesis, biomarkers and clinical challenges in Parkinson’s and MSA.
SYMPATH is an EU-funded project within the seventh framework programme.
Gergana Galabova, AFFiRiS AG; Wassilios Meissner, University Hospital Bordeaux; Günther Staffler, AFFiRiS AG
Please visit the meeting website for further information.
IMP Lecture Hall